Chairman of Haofeng Medical, Liu Chunjie, stated"In recent years, the high-value medical consumables market in China has experienced vigorous growth, driven by strong demand, the pursuit of high-quality products, and the localization of supply chains, propelling the rapid development of the domestic medical device industry. The medical device industry requires not only production capacity but also high-quality capacity. How to develop new productive forces for the industry and continuously empower customer innovation is the top priority of our CDMO industry work. Haofeng Medical has been deeply engaged in the high-value medical consumables sector for many years, building an intelligent equipment, component CDMO, and materials integrated service platform. We understand the urgency and importance of platform-based services in meeting the diverse needs of downstream customers. The company is committed to becoming a lean production expert in the medical device field, providing customers with a high-quality, efficient, and comprehensive medical device service supply chain. We sincerely thank both new and existing shareholders for their recognition of Haofeng Medical. The company will forge ahead, stay true to its original mission, and strive to build the number one CDMO brand in the medical device industry, becoming a trusted strategic partner for global medical device companies."

Zhuhai High-tech Golden Investment stated"Interventional medical devices are one of the fastest-growing medical device sectors in China. High-tech investment firms have been closely monitoring the development of China's high-end medical device sector, showing a strong interest in investment opportunities within the increasingly prominent domestic interventional medical device sub-industry in recent years. Haofeng Medical, as a one-stop service platform for downstream interventional medical device clients, provides the highest quality industrial chain services in the industry. The company has a well-established commercial layout in the field of interventional medical devices and maintains deep client relationships. We look forward to Haofeng Medical becoming a trusted service provider in the medical device supply chain, continuously supporting the growth and development of China’s interventional medical device industry."

Qianji Capital stated"Qianji has long been focused on opportunities across the entire medical device industry chain. After more than a decade of development, the innovation capabilities of domestic device companies in China have steadily strengthened, and the demands for efficiency in production and R&D have also increased significantly. The industry division of labor has become more defined, and the upstream sector of medical devices is approaching an inflection point for growth. Leveraging years of expertise in interventional product equipment and processes, combined with the team's advantage in lean management, Haofeng Medical has established a one-stop interventional device CDMO. We hope to continuously support the company’s development and provide higher quality and more efficient services to clients in China and globally."

Lu Rongchao, partner of Xi Qiao Capital, said"Congratulations to Haofeng Medical for successfully completing two rounds of financing within the year. I have personally witnessed the company's rapid development and innovative transformation over the past three years. The medical device CDMO is a field that truly tests a company’s patience, resilience, and comprehensive operational capabilities. Under the leadership of Founder and CEO Mr. Liu, I believe the team will continue to provide high-value services to downstream clients and become a globally leading brand in the medical device CDMO sector."

More exciting content

Welcome to follow WeChat Video Channel

Instrument Family